Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Epirus Biopharmaceuticals Inc    EPRSQ

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
04/24/2017 04/25/2017 04/26/2017 04/27/2017 04/28/2017 Date
0.019(c) 0.0199(c) 0.0135(c) 0.018(c) 0.018(c) Last
168 640 39 421 301 22 480 10 745 Volume
0.00% +4.74% -32.16% +33.33% 0.00% Change
More quotes
Company
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business.It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference... 
More about the company
Latest news on EPIRUS BIOPHARMACEUTICALS
2016 EPIRUS BIOPHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Co..
2016 EPIRUS BIOPHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Te..
2016 EPIRUS BIOPHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Ot..
2016 EPIRUS BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial Co..
2016 EPIRUS BIOPHARMACEUTICALS : Announces Reprioritization of Pipeline to Solely Foc..
2016 TUESDAY SECTOR LAGGARDS : Apparel Stores, Biotechnology Stocks
2016 EPIRUS BIOPHARMACEUTICALS, INC. : Costs Associated with Exit or Disposal Activit..
2016 EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars ..
2016 EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financi..
2016 EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Fina..
More news
Sector news : Biotechnology & Medical Research - NEC
04/28 REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
04/28DJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
04/27 AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart EPIRUS BIOPHARMACEUTICALS
Duration : Period :
Epirus Biopharmaceuticals  Technical Analysis Chart | EPRSQ | US29428P1075 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Sector and Competitors
1st jan.Capitalization (M$)
EPIRUS BIOPHARMACEUTIC..-36.84%0
INCYTE CORPORATION23.95%25 426
QUINTILES IMS HOLDINGS..10.82%19 884
LONZA GROUP AG17.13%11 836
SEATTLE GENETICS, INC.29.43%9 741
CELLTRION, INC.--.--%9 653
More Results